Corrigendum to "Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease" [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582]. - 2024
Corrigendum to "Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease" [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582].
Guiot, Julien ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Miedema, Jelle; Center of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Pulmonology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: j.miedema@erasmusmc.nl
De Vries-Bouwstra, Jeska K; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: J.K.de_Vries-Bouwstra@lumc.nl
Dimitroulas, Theodoros; 4th Department of Internal Medicine, Hippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Søndergaard, Klaus; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: klausoen@rm.dk
Tzouvelekis, Argyrios; Department of Respiratory Medicine, University of Patras, Patras, Greece
Smith, Vanessa; Department of Internal Medicine, Ghent University, Ghent, Belgium, Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium. Electronic address: vanessa.smith@ugent.be
Language :
English
Title :
Corrigendum to "Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease" [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582].
Alternative titles :
[en] Corrigendum to “Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease” [Autoimmunity Reviews - Volume 23, Issue 6, June 2024, 103582](S1568997224000739)(10.1016/j.autrev.2024.103582)
Medical writing assistance, in the form of the preparation and revision of the draft manuscript, was supported financially by Boehringer Ingelheim and provided by Hedwig Stals of HD Consultancy BV under the authors' conceptual direction and based on feedback from the authors.
